BRNS
Barinthus Biotherapeutics
BRNS
BRNS
13 hedge funds and large institutions have $48.3M invested in Barinthus Biotherapeutics in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 15 → 13 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Holders
13
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$119K | |
| 2 | +$84.3K | |
| 3 | +$76.7K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$11.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$3.13K |
Top Sellers
| 1 | -$1.89M | |
| 2 | -$25K | |
| 3 | -$19K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$16.3K |
| 5 |
Morgan Stanley
New York
|
-$1.53K |
